These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 3039645
1. Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies. Dawson DM, Carter JL, Hafler DA, Weiner HL. Riv Neurol; 1987; 57(2):88-91. PubMed ID: 3039645 [Abstract] [Full Text] [Related]
2. Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients. Carter JL, Hafler DA, Dawson DM, Orav J, Weiner HL. Neurology; 1988 Jul; 38(7 Suppl 2):9-14. PubMed ID: 2838768 [Abstract] [Full Text] [Related]
7. Effects of immunosuppressive agents and particularly of cyclophosphamide on lymphocytes subsets in treated multiple sclerosis patients. Gonsette RE, Defalque A, Demonty L. Riv Neurol; 1987 Jul; 57(3):181-4. PubMed ID: 2960008 [Abstract] [Full Text] [Related]
8. [Immunosuppressive treatment im multiple sclerosis]. Mertin J. Fortschr Med; 1980 Oct 02; 98(37):1431-6. PubMed ID: 6253370 [Abstract] [Full Text] [Related]
9. Experience with cyclophosphamide in multiple sclerosis: the cons. Likosky WH. Neurology; 1988 Jul 02; 38(7 Suppl 2):14-8. PubMed ID: 3290708 [Abstract] [Full Text] [Related]
20. Double-blind study of true vs. sham plasmapheresis in patients being treated with immunosuppression for acute attacks of multiple sclerosis. Weiner HL, Dau PC, Khatri BO, Petajan J, Birnbaum G, McQuillen MP, Fosburg MT, Feldstein M, Orav J. Prog Clin Biol Res; 1990 Jun 29; 337():283. PubMed ID: 2162062 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]